Free Trial

Y-mAbs Therapeutics (YMAB) SEC Filings & 10K Form

Y-mAbs Therapeutics logo
$4.96 +0.12 (+2.48%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$4.95 -0.01 (-0.20%)
As of 03/27/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Y-mAbs Therapeutics SEC Filings

DateFilerForm TypeView
03/11/2025
7:15 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:17 PM
Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:32 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
3:36 PM
Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
3:40 PM
Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
3:26 PM
Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:48 AM
Y-mAbs Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
6:15 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
6:24 AM
Y-mAbs Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/22/2025
5:57 PM
LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:00 PM
Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:01 PM
Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:03 PM
Gentilcore Douglas J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:04 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:05 PM
PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:44 PM
LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/13/2025
8:21 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
8:27 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:32 PM
Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
11/08/2024
6:18 AM
Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
5:55 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:16 PM
VANGUARD GROUP INC (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
11/04/2024
7:51 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
7:05 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:24 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:19 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
6:06 AM
Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
5:50 AM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:15 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:29 PM
PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:59 PM
PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2024
3:20 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
8:00 PM
TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:00 PM
GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM
HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM
Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM
Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM
TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
6:53 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:54 PM
Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
06/10/2024
3:44 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
8:36 PM
Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:54 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:42 PM
Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2024
4:04 PM
Y-mAbs Therapeutics (Filer)
Form DEFA14A
04/29/2024
4:05 PM
Y-mAbs Therapeutics (Filer)
Form ARS
04/29/2024
4:09 PM
Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
4:09 PM
Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:YMAB) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners